TRIM25 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.307000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.099000E-01
Normal-vs-Stage2
3.317200E-01
Normal-vs-Stage3
2.511800E-01
Normal-vs-Stage4
1.412050E-01
Stage1-vs-Stage2
2.704000E-01
Stage1-vs-Stage3
2.832400E-02
Stage1-vs-Stage4
1.066350E-01
Stage2-vs-Stage3
1.750400E-01
Stage2-vs-Stage4
2.316600E-01
Stage3-vs-Stage4
9.090200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.327200E-01
Normal-vs-AfricanAmerican
3.302600E-01
Normal-vs-Asian
3.378400E-01
Caucasian-vs-AfricanAmerican
9.018000E-01
Caucasian-vs-Asian
9.817200E-01
AfricanAmerican-vs-Asian
9.412800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.366200E-01
Normal-vs-Female
3.263800E-01
Male-vs-Female
6.320000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.905800E-01
Normal-vs-Age(41-60Yrs)
3.456000E-01
Normal-vs-Age(61-80Yrs)
3.244600E-01
Normal-vs-Age(81-100Yrs)
3.260400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.695800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.069000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.908400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.425600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.741600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.955800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.983400E-01
Normal-vs-Daily Drinker
2.816200E-01
Normal-vs-Weekly Drinker
3.354600E-01
Normal-vs-Occasional Drinker
3.291600E-01
Normal-vs-Social Drinker
3.970000E-01
Non Drinker-vs-Daily Drinker
5.846000E-01
Non Drinker-vs-Weekly Drinker
4.365600E-01
Non Drinker-vs-Occasional Drinker
4.543000E-01
Non Drinker-vs-Social Drinker
2.029900E-02
Daily Drinker-vs-Weekly Drinker
1.996600E-01
Daily Drinker-vs-Occasional Drinker
1.981580E-01
Daily Drinker-vs-Social Drinker
1.096350E-03
Weekly Drinker-vs-Occasional Drinker
9.257600E-01
Weekly Drinker-vs-Social Drinker
2.405200E-01
Occasional Drinker-vs-Social Drinker
1.522830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.175810E-01
Normal-vs-Grade 2
2.159600E-01
Normal-vs-Grade 3
1.652390E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.702400E-01
Grade 1-vs-Grade 3
6.863400E-01
Grade 1-vs-Grade 4
1.175810E-01
Grade 2-vs-Grade 3
8.538000E-01
Grade 2-vs-Grade 4
2.159600E-01
Grade 3-vs-Grade 4
1.652390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.199600E-01
Normal-vs-NonDiabetic
3.242600E-01
Diabetic-vs-NonDiabetic
8.499200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.470600E-01
Normal-vs-NoPancreatitis
3.180200E-01
Pancreatitis-vs-NoPancreatitis
5.797600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.455800E-01
Normal-vs-N1
3.264400E-01
N0-vs-N1
4.465800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.202200E-01
Normal-vs-TP53-NonMutant
4.194000E-01
TP53-Mutant-vs-TP53-NonMutant
3.615100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
